清热解毒中药及其有效成分干预2型糖尿病的研究进展
Research Progress of Clearing Heat and Detoxifying Chinese Medicine and Its Active Ingredients in the Intervention of 2 Diabetes
摘要: 2型糖尿病(T2DM)是慢性代谢性疾病之一，中国作为糖尿病患病率增长大国，如何有效治疗T2DM、提高患者生存质量亟待解决。中医药多靶点、副作用小的优势，已成为T2DM临床治疗和延缓疾病进展的有效策略。清热解毒药是以解热毒、火毒、疫毒为主的一类药物，针对临床“热毒炽盛证”的T2DM患者有效。本文对清热解毒中药及其有效成分干预T2DM的研究现状进行总结，以期为寻找防治T2DM的中药提供可行性靶点。
Abstract: Type 2 Diabetes (T2DM) is one of the chronic metabolic diseases. As a large country with a growing prevalence of diabetes, how to effectively treat T2DM and improve the quality of survival in patients needs to be resolved. The advantages of multiple targets and side effects of traditional Chinese medicine have become an effective strategy for T2DM clinical treatment and delaying disease progress. Clear heat and detoxification is a type of drug mainly based on thermal poisoning, fire poison, and epidemic poison. Patients with T2DM for clinical “thermal poisoning” are effective. This article summarizes the current status of the research status of T2DM intervention in clearing heat and detoxifying Chinese medicine and its effective ingredients, in order to provide feasible targets for finding Chinese medicines for preventing and controlling T2DM.
文章引用：韩慧子, 刘婷, 俞琦. 清热解毒中药及其有效成分干预2型糖尿病的研究进展[J]. 临床医学进展, 2022, 12(12): 12015-12020. https://doi.org/10.12677/ACM.2022.12121731

参考文献

[1] Cho, N.H., Shaw, J.E., Karuranga, S., et al. (2018) IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281. [Google Scholar] [CrossRef] [PubMed]
[2] Grøndahl, M.F.G., Johannesen, J., Kristensen, K., et al. (2021) Treatment of Type 2 Diabetes in Children: What Are the Specific Considerations. Expert Opinion on Pharmacotherapy, 22, 2127-2141. [Google Scholar] [CrossRef] [PubMed]
[3] Demir, S., Nawroth, P.P., Herzig, S., et al. (2021) Emerging Targets in Type 2 Diabetes and Diabetic Complications. Advanced Science (Weinh), 8, e2100275. [Google Scholar] [CrossRef] [PubMed]
[4] Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., et al. (2017) IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40-50. [Google Scholar] [CrossRef] [PubMed]
[5] Taylor, R. (2008) Pathogenesis of Type 2 Diabetes: Tracing the Reverse Route from Cure to Cause. Diabetologia, 51, 1781-1789. [Google Scholar] [CrossRef] [PubMed]
[6] Taylor, R. (2021) Type 2 Diabetes and Remission: Practical Management Guided by Pathophysiology. Journal of Internal Medicine, 289, 754-770. [Google Scholar] [CrossRef] [PubMed]
[7] Batista, T.M., Haider, N. and Kahn, C.R. (2021) Defining the Underlying Defect in Insulin Action in Type 2 Diabetes. Diabetologia, 64, 994-1006. [Google Scholar] [CrossRef] [PubMed]
[8] Costes, S., Bertrand, G. and Ravier, M.A. (2021) Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies. In-ternational Journal of Molecular Sciences, 22, 5303. [Google Scholar] [CrossRef] [PubMed]
[9] Halban, P.A., Polonsky, K.S., Bowden, D.W., et al. (2014) β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment. Diabetes Care, 37, 1751-1758. [Google Scholar] [CrossRef] [PubMed]
[10] Moin, A.S.M. and Butler, A.E. (2019) Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes. Current Diabetes Reports, 19, 83. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, J., Ma, Q., Li, Y., et al. (2020) Research Progress on Traditional Chinese Medicine Syndromes of Diabetes Mellitus. Biomedicine & Pharmacotherapy, 121, Article ID: 109565. [Google Scholar] [CrossRef] [PubMed]
[12] 郭小舟, 陶夏平, 王斌. 从湿热瘀毒论治糖尿病[J]. 中国中医基础医学杂志, 2021, 27(6): 1017-1018+1021.
[13] 杨梦依, 倪海祥. 从湿热论治新诊断2型糖尿病[J]. 浙江中西医结合杂志, 2021, 31(11): 1071-1074.
[14] 严龙. 中药仙茅在大鼠体内的PK-PD模型初探[D]: [硕士学位论文]. 曲阜: 曲阜师范大学, 2014.
[15] 杨彬, 马景, 俞恒桑, 等. 凉膈散与黄连解毒汤对2型糖尿病小鼠血糖、血脂及胰岛素水平的影响[J]. 浙江中西医结合杂志, 2009, 19(6): 337-338.
[16] 黄秀芳, 陶彦谷, 张茹兰, 等. 黄连解毒汤对胰岛素抵抗大鼠炎症因子和氧化应激水平的影响[J]. 中国中医药科技, 2017, 24(5): 572-574+583.
[17] 苟芳, 张红军, 王洁, 等. 黄连解毒汤通过抑制TGF-β信号通路减轻2型糖尿病大鼠肝脂肪变性和纤维化研究[J]. 陕西中医, 2022, 43(2): 170-176.
[18] 刘巧, 胡慧玲, 岳青, 等. 三黄泻心汤对II型糖尿病大鼠的降血糖作用研究[J]. 中药与临床, 2018, 9(2): 43-47.
[19] 张益钧, 沈利水, 戴盛锋, 等. 三黄汤与普济消毒饮干预2型糖尿病小鼠胰岛素信号错误转导的机理研究[J]. 中医药学报, 2009, 37(2): 25-28.
[20] Furman, B.L., Candasamy, M., Bhattamisra, S.K., et al. (2020) Reduction of Blood Glucose by Plant Extracts and Their Use in the Treatment of Diabetes Mellitus: Discrepancies in Effectiveness between Animal and Human Studies. Journal of Ethnopharmacology, 247, Article ID: 112264. [Google Scholar] [CrossRef] [PubMed]
[21] 黄永亮, 吴纯洁, 何晓燕. 中药提取工艺评价指标的研究进展[J]. 中药与临床, 2012, 3(5): 49-52.
[22] Cui, X., Qian, D.W., Jiang, S., et al. (2018) Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Ratsvia Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway. International Journal of Molecular Sciences, 19, 3634. [Google Scholar] [CrossRef] [PubMed]
[23] Xiao, S., Liu, C., Chen, M., et al. (2020) Scutellariae Radix and Coptidisrhizoma Ameliorate Glyeolipid Metabolism of Type 2 Diabetic Rats by Modulating Gut Microbiota and Its Metabolites. Applied Microbiology and Biotechnology, 104, 303-317. [Google Scholar] [CrossRef] [PubMed]
[24] 郭志利, 左晓琦, 张梅, 等. 黄连对2型糖尿病大鼠调节性T细胞及相关炎症因子的影响[J]. 现代中西医结合杂志, 2022, 31(5): 619-623+717.
[25] Yu, M., Han, S., Wang, M., et al. (2022) Baicalin Protects against Insulin Resistance and Metabolic Dysfunction through Activation of GALR2/GLUT4 Signaling. Phytomedicine, 95, Article ID: 153869. [Google Scholar] [CrossRef] [PubMed]
[26] 闫爽, 李光耀, 戴丛书, 等. 蒲公英提取物对2型糖尿病大鼠降血糖的作用[J]. 食品与机械, 2020, 36(11): 138-142.
[27] 王成祥, 刘玉霞, 常绍鸿, 等. 马齿苋多糖对幼年糖尿病大鼠糖脂代谢、肾功能的影响及其作用机制[J]. 中国医科大学学报, 2021, 50(1): 46-50+56.
[28] 鱼晓敏, 安馨, 鲁慧, 王兴婷, 江岩. 桑叶水提物与醇提物对糖尿病小鼠的协同降血糖效应[J]. 卫生研究, 2018, 47(3): 432-436
[29] 孙文杰, 赵能江, 李博, 等. 《中国2型糖尿病防治指南(2020年版)》推荐中成药品种述评[J]. 中国中医药信息杂志, 2022, 29(3): 1-5.
[30] 马明华, 戴媛媛, 汪晓河, 等. 2015年版中国药典收载的治疗糖尿病的中成药组方药味特点研究[J]. 上海医药, 2020, 41(3): 31-34.
[31] 杨亚男, 李艳杰, 陈玉鹏, 等. 已上市中成药治疗糖尿病的用药规律及核心处方挖掘[J]. 世界中医药, 2022, 17(3): 418-423.
[32] 王芳玲, 田风胜, 王元松, 等. 三黄片对糖尿病模型大鼠氧化应激水平的影响实验[J]. 河北中医, 2015, 37(7): 1031-1034.
[33] 周金芳, 宋菊敏, 刘小美, 等. 复方黄连降糖片对GK大鼠糖脂代谢紊乱的影响[J]. 辽宁中医药大学学报, 2011, 13(4): 110-112.
[34] 魏萍. 基于InsR-PI3K-Akt信号通路探讨金芪降糖片改善细胞胰岛素抵抗的机制[D]: [硕士学位论文]. 北京: 北京中医药大学, 2021.
[35] 唐程, 朴春丽, 王丽, 等. 糖尿病前期中西医治疗进展[J]. 吉林中医药, 2021, 41(3): 416-420.
[36] 路建刚. 中西医结合治疗2型糖尿病的临床效果观察[J]. 黑龙江科学, 2022, 13(4): 132-133.

为你推荐